Which has preferable valuation & earnings, ENGNW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enGene N/A N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is ENGNW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets enGene N/A N/A N/A Alvotech N/A N/A N/A

Does the media prefer ENGNW or ALVOW?

In the previous week, enGene had 21 more articles in the media than Alvotech. MarketBeat recorded 24 mentions for enGene and 3 mentions for Alvotech. Alvotech's average media sentiment score of 0.20 beat enGene's score of -0.08 indicating that Alvotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment enGene 3 Very Positive mention(s) 1 Positive mention(s) 13 Neutral mention(s) 3 Negative mention(s) 4 Very Negative mention(s) Neutral Alvotech 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, ENGNW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enGene N/A N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is ENGNW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets enGene N/A N/A N/A Apollomics N/A N/A N/A

Which has preferable valuation & earnings, ENGNW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enGene N/A N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is ENGNW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets enGene N/A N/A N/A Aravive N/A N/A N/A

Which has better valuation and earnings, ENGNW or BIAFW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enGene N/A N/A N/A N/A N/A bioAffinity Technologies $5.85M N/A N/A N/A N/A

Is ENGNW or BIAFW more profitable?

Company Net Margins Return on Equity Return on Assets enGene N/A N/A N/A bioAffinity Technologies N/A N/A N/A

Does the media refer more to ENGNW or BIAFW?

In the previous week, enGene had 22 more articles in the media than bioAffinity Technologies. MarketBeat recorded 24 mentions for enGene and 2 mentions for bioAffinity Technologies. enGene's average media sentiment score of -0.08 beat bioAffinity Technologies' score of -1.10 indicating that enGene is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment enGene 3 Very Positive mention(s) 1 Positive mention(s) 13 Neutral mention(s) 3 Negative mention(s) 4 Very Negative mention(s) Neutral bioAffinity Technologies 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Negative

Which has higher valuation and earnings, ENGNW or BIVIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enGene N/A N/A N/A N/A N/A BioVie N/A N/A N/A N/A N/A

Is ENGNW or BIVIW more profitable?

Company Net Margins Return on Equity Return on Assets enGene N/A N/A N/A BioVie N/A N/A N/A

Does the media prefer ENGNW or BIVIW?

In the previous week, enGene had 22 more articles in the media than BioVie. MarketBeat recorded 24 mentions for enGene and 2 mentions for BioVie. BioVie's average media sentiment score of 0.55 beat enGene's score of -0.08 indicating that BioVie is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment enGene 3 Very Positive mention(s) 1 Positive mention(s) 13 Neutral mention(s) 3 Negative mention(s) 4 Very Negative mention(s) Neutral BioVie 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

enGene (ENGNW) Competitors

$0.25 +0.00 (+0.04%)

Closing price 09/22/2026 04:26 PM Eastern

Extended Trading

$0.25 0.00 (0.00%)

As of 09/22/2026 04:26 PM Eastern

Compare

ENGNW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy enGene stock or one of its competitors? enGene's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does enGene compare to Alvotech?

enGene (NASDAQ:ENGNW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Company	Net Margins	Return on Equity	Return on Assets
enGene	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enGene	N/A	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

In the previous week, enGene had 21 more articles in the media than Alvotech. MarketBeat recorded 24 mentions for enGene and 3 mentions for Alvotech. Alvotech's average media sentiment score of 0.20 beat enGene's score of -0.08 indicating that Alvotech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
enGene	3 Very Positive mention(s)	1 Positive mention(s)	13 Neutral mention(s)	3 Negative mention(s)	4 Very Negative mention(s)	Neutral
Alvotech	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Alvotech beats enGene on 2 of the 3 factors compared between the two stocks.

How does enGene compare to Apollomics?

enGene (NASDAQ:ENGNW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
enGene	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enGene	N/A	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

In the previous week, enGene had 24 more articles in the media than Apollomics. MarketBeat recorded 24 mentions for enGene and 0 mentions for Apollomics. Apollomics' average media sentiment score of 0.00 beat enGene's score of -0.08 indicating that Apollomics is being referred to more favorably in the news media.

Company	Overall Sentiment
enGene	Neutral
Apollomics	Neutral

Summary

Apollomics beats enGene on 2 of the 3 factors compared between the two stocks.

How does enGene compare to Aravive?

enGene (NASDAQ:ENGNW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

Company	Net Margins	Return on Equity	Return on Assets
enGene	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enGene	N/A	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

In the previous week, enGene had 24 more articles in the media than Aravive. MarketBeat recorded 24 mentions for enGene and 0 mentions for Aravive. Aravive's average media sentiment score of 0.00 beat enGene's score of -0.08 indicating that Aravive is being referred to more favorably in the news media.

Company	Overall Sentiment
enGene	Neutral
Aravive	Neutral

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Aravive beats enGene on 3 of the 4 factors compared between the two stocks.

How does enGene compare to bioAffinity Technologies?

enGene (NASDAQ:ENGNW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, risk and valuation.

In the previous week, enGene had 22 more articles in the media than bioAffinity Technologies. MarketBeat recorded 24 mentions for enGene and 2 mentions for bioAffinity Technologies. enGene's average media sentiment score of -0.08 beat bioAffinity Technologies' score of -1.10 indicating that enGene is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
enGene	3 Very Positive mention(s)	1 Positive mention(s)	13 Neutral mention(s)	3 Negative mention(s)	4 Very Negative mention(s)	Neutral
bioAffinity Technologies	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Negative

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enGene	N/A	N/A	N/A	N/A	N/A
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
enGene	N/A	N/A	N/A
bioAffinity Technologies	N/A	N/A	N/A

Summary

enGene beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does enGene compare to BioVie?

enGene (NASDAQ:ENGNW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enGene	N/A	N/A	N/A	N/A	N/A
BioVie	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
enGene	N/A	N/A	N/A
BioVie	N/A	N/A	N/A

In the previous week, enGene had 22 more articles in the media than BioVie. MarketBeat recorded 24 mentions for enGene and 2 mentions for BioVie. BioVie's average media sentiment score of 0.55 beat enGene's score of -0.08 indicating that BioVie is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
enGene	3 Very Positive mention(s)	1 Positive mention(s)	13 Neutral mention(s)	3 Negative mention(s)	4 Very Negative mention(s)	Neutral
BioVie	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

enGene and BioVie tied by winning 1 of the 2 factors compared between the two stocks.

Get enGene News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ENGNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ENGNW vs. The Competition

Export

Metric	enGene	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$3.96B	$7.28B	$13.20B
Dividend Yield	N/A	3.64%	2.53%	13.00%
P/E Ratio	N/A	14.45	274.54	25.75
Price / Sales	N/A	1,381.81	655.98	89.98
Price / Cash	N/A	109.50	76.31	52.02
Price / Book	N/A	15.54	10.58	6.36
Net Income	N/A	-$22.82M	$3.49B	$360.20M
7 Day Performance	N/A	1.87%	1.92%	2.22%
1 Month Performance	-41.87%	-4.06%	-2.14%	-2.95%
1 Year Performance	-70.93%	38.49%	17.98%	6.46%

enGene Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ENGNW enGene	N/A	$0.25 +0.0%	N/A	-71.0%	$0.00	N/A	N/A	31	Gap Up
ALVOW Alvotech	N/A	$0.33 +10.8%	N/A	-75.2%	$0.00	$491.95M	N/A	4	Gap Up
APLMW Apollomics	N/A	$0.01 flat	N/A	-39.3%	$0.00	$8.50M	N/A	59	Positive News Upcoming Earnings
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.20 -16.9%	N/A	+297.1%	$0.00	$5.85M	N/A	10	News Coverage Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ENGNW) was last updated on 9/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

enGene (ENGNW) Competitors